Compare BN & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BN | MDT |
|---|---|---|
| Founded | 1997 | 1949 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.6B | 107.0B |
| IPO Year | 1998 | 2014 |
| Metric | BN | MDT |
|---|---|---|
| Price | $40.31 | $94.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 21 |
| Target Price | $49.87 | ★ $108.21 |
| AVG Volume (30 Days) | 3.6M | ★ 7.0M |
| Earning Date | 05-14-2026 | 06-03-2026 |
| Dividend Yield | 0.58% | ★ 3.58% |
| EPS Growth | N/A | ★ 3.32 |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $36,364,000,000.00 |
| Revenue This Year | N/A | $8.91 |
| Revenue Next Year | $16.74 | $6.54 |
| P/E Ratio | $93.92 | ★ $24.82 |
| Revenue Growth | N/A | ★ 8.43 |
| 52 Week Low | $37.93 | $73.31 |
| 52 Week High | $74.20 | $106.33 |
| Indicator | BN | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 60.46 |
| Support Level | $37.93 | $85.35 |
| Resistance Level | $48.14 | $94.72 |
| Average True Range (ATR) | 0.70 | 2.14 |
| MACD | -0.25 | -0.27 |
| Stochastic Oscillator | 18.05 | 48.08 |
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.